BIOPHARMACEUTICAL COLD CHAIN ENGINEERING

Confidence in your cold chain. Guaranteed.

Modality Solutions provides cold chain engineering, packaging qualification, and drug product transport simulation for the biopharmaceutical industry. We design, calibrate, and validate your cold chain network to global regulatory standards. We own and operate the only independent multi-variable transport simulation laboratory. Our technology concurrently replicates the five key environmental hazards that impact product quality: temperature, shock, vibration, humidity, and pressure. Learn more at www.modality-solutions.com.

REGULATORY FILING SUPPORT 

Transport Simulation Laboratory

Thermal Engineering

Transport Validation 

COLD CHAIN OPERATIONS

Cold Chain Logistics

Clinical Trial Operations

 Technology

INTEGRATED EXPERTISE

Project Based

Staff Augmentation

Outsourced

Schedule your free one-hour, no obligation consultation.

If you work with us, this is what you can expect:

  • Confidence in your cold chain. Guaranteed.
  • Every engagement led by a principal.
  • Reach out anytime, anywhere, for anything.
  • We solve real problems. Your cold chain will be approved.
  • You will become a cold chain expert.

Let’s start a conversation! 

Call us today at (888) 219-6317

Email: info@modality-solutions.com 

Click here to schedule your free one-hour, no obligation consult.

Go to article: Home | The dengue dilemma Go to article: In this issueGo to article: Owen MumfordGo to article: ContentsGo to article: Hapa Company Insight Go to article: Daiichi JitsugyoGo to article: NewsGo to article: EmbocapsGo to article: HOF Sonderanlagenbau Company Insight Go to article: HOF SonderanlagenbauGo to article: The pharma industry briefingGo to article: Dow Europe Company InsightGo to article: Gerteis Company InsightGo to article: GerteisGo to article: The problem of manipulated data Go to article: Capsugel Company Insight Go to article: CapsugelGo to article: Timeline: the dengue vaccine dilemmaGo to article: TSS Company Insight Go to article: TSSGo to article: From evergreening to thicketing: exploring manipulation of the pharma patent sysGo to article: Emirates SkyCargoGo to article: AtoZ-CRO Company InsightGo to article: AtoZ-CROGo to article: A safer ride: the latest innovation in targeted cancer treatment Go to article: Swiss WorldCargoGo to article: Accurate BiometricsGo to article: Accurate Biometrics Company Insight Go to article: Nelson LabsGo to article: Treading the line: the challenge of transplant rejection drugsGo to article: Corbion PuracGo to article: Erdmann Design Company InsightGo to article: Erdmann Design SwitzerlandGo to article: Treating menopause: at last a non-hormonal alternative? Go to article: YourwayGo to article: ImmuMap Company Insight Go to article: ImmuMapGo to article: Drug repurposing: the industry’s all-rounder medicinesGo to article: FargoGo to article: Pharma Support Services Company InsightGo to article: Pharma Support ServicesGo to article: One step closer to a Chlamydia vaccine Go to article: AralabGo to article: Synex SyntheticsGo to article: Deals in brief powered by GlobalDataGo to article: Charles Ischi Go to article: The key list powered by GlobalDataGo to article: Pharmaceutical Solutions IndustryGo to article: Clinichain Company Insight Go to article: ClinichainGo to article: SanofiGo to article: EventsGo to article: NymiGo to article: Modality SolutionsGo to article: PfanstiehlGo to article: Next issueGo to article: MimotopesGo to article: ICCI - International Cannabis and Cannabinoids Institute Go to article: ICCI